Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16454 | 652 | 41.8 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
76 | 3 | NEUROSCIENCES//DOPAMINE//SEROTONIN | 81359 |
75 | 2 | NUCLEUS ACCUMBENS//DOPAMINE//COCAINE | 27976 |
16454 | 1 | 6 HYDROXYDOPAMINE//SUPERSENSITIZATION//CELLULAR CLIN NEUROBIOL PROGRAM | 652 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 6 HYDROXYDOPAMINE | authKW | 216740 | 13% | 5% | 88 |
2 | SUPERSENSITIZATION | authKW | 180628 | 1% | 43% | 9 |
3 | CELLULAR CLIN NEUROBIOL PROGRAM | address | 164208 | 2% | 22% | 16 |
4 | NEONATAL 6 HYDROXYDOPAMINE | authKW | 149861 | 1% | 80% | 4 |
5 | SEROTONIN HYPERINNERVATION | authKW | 140496 | 0% | 100% | 3 |
6 | RECEPTOR SUPERSENSITIVITY | authKW | 140484 | 1% | 33% | 9 |
7 | ORAL ACTIVITY | authKW | 126434 | 1% | 30% | 9 |
8 | QUILLEN MED | address | 95296 | 4% | 8% | 25 |
9 | NEONATAL DOPAMINE LESION | authKW | 93664 | 0% | 100% | 2 |
10 | PREPROENKEPHALIN MESSENGER RNA | authKW | 88726 | 1% | 32% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 11534 | 76% | 0% | 493 |
2 | Pharmacology & Pharmacy | 1109 | 26% | 0% | 167 |
3 | Behavioral Sciences | 967 | 9% | 0% | 59 |
4 | Developmental Biology | 800 | 7% | 0% | 48 |
5 | Psychiatry | 145 | 6% | 0% | 42 |
6 | Psychology | 53 | 2% | 0% | 16 |
7 | Clinical Neurology | 16 | 4% | 0% | 25 |
8 | Medicine, Research & Experimental | 8 | 3% | 0% | 17 |
9 | Biochemistry & Molecular Biology | 7 | 8% | 0% | 52 |
10 | Endocrinology & Metabolism | 7 | 3% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELLULAR CLIN NEUROBIOL PROGRAM | 164208 | 2% | 22% | 16 |
2 | QUILLEN MED | 95296 | 4% | 8% | 25 |
3 | 6767 W OUTER DR | 46832 | 0% | 100% | 1 |
4 | CLIN PUERTO HIERRO | 46832 | 0% | 100% | 1 |
5 | ENGN MACHINERY ELECT | 46832 | 0% | 100% | 1 |
6 | MED PSYCHIAT BRAIN DEV | 46832 | 0% | 100% | 1 |
7 | MED RECH NEUROBIOL | 46832 | 0% | 100% | 1 |
8 | MOLEC INTEGRATIVE NEUROSCI | 46832 | 0% | 100% | 1 |
9 | NEUROBIOL CELLULAIRE FONCT UPR 9013 | 46832 | 0% | 100% | 1 |
10 | PROGRAM NEUROSCI NEUROPHARMACOL | 46832 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR BRAIN RESEARCH | 13437 | 6% | 1% | 36 |
2 | NEUROTOXICITY RESEARCH | 10734 | 2% | 2% | 15 |
3 | DEVELOPMENTAL BRAIN RESEARCH | 7285 | 4% | 1% | 28 |
4 | BRAIN RESEARCH | 5826 | 12% | 0% | 77 |
5 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 4855 | 6% | 0% | 36 |
6 | SYNAPSE | 3191 | 2% | 0% | 15 |
7 | DEVELOPMENTAL PSYCHOBIOLOGY | 2576 | 2% | 1% | 11 |
8 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2099 | 5% | 0% | 31 |
9 | PSYCHOPHARMACOLOGY | 2020 | 4% | 0% | 23 |
10 | JOURNAL OF NEUROCHEMISTRY | 1854 | 4% | 0% | 29 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 6 HYDROXYDOPAMINE | 216740 | 13% | 5% | 88 | Search 6+HYDROXYDOPAMINE | Search 6+HYDROXYDOPAMINE |
2 | SUPERSENSITIZATION | 180628 | 1% | 43% | 9 | Search SUPERSENSITIZATION | Search SUPERSENSITIZATION |
3 | NEONATAL 6 HYDROXYDOPAMINE | 149861 | 1% | 80% | 4 | Search NEONATAL+6+HYDROXYDOPAMINE | Search NEONATAL+6+HYDROXYDOPAMINE |
4 | SEROTONIN HYPERINNERVATION | 140496 | 0% | 100% | 3 | Search SEROTONIN+HYPERINNERVATION | Search SEROTONIN+HYPERINNERVATION |
5 | RECEPTOR SUPERSENSITIVITY | 140484 | 1% | 33% | 9 | Search RECEPTOR+SUPERSENSITIVITY | Search RECEPTOR+SUPERSENSITIVITY |
6 | ORAL ACTIVITY | 126434 | 1% | 30% | 9 | Search ORAL+ACTIVITY | Search ORAL+ACTIVITY |
7 | NEONATAL DOPAMINE LESION | 93664 | 0% | 100% | 2 | Search NEONATAL+DOPAMINE+LESION | Search NEONATAL+DOPAMINE+LESION |
8 | PREPROENKEPHALIN MESSENGER RNA | 88726 | 1% | 32% | 6 | Search PREPROENKEPHALIN+MESSENGER+RNA | Search PREPROENKEPHALIN+MESSENGER+RNA |
9 | PREPROENKEPHALIN MRNA | 88726 | 1% | 32% | 6 | Search PREPROENKEPHALIN+MRNA | Search PREPROENKEPHALIN+MRNA |
10 | PREPROTACHYKININ | 83315 | 2% | 16% | 11 | Search PREPROTACHYKININ | Search PREPROTACHYKININ |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KOSTRZEWA, RM , KOSTRZEWA, JP , BRUS, R , (2003) DOPAMINE RECEPTOR SUPERSENSITIVITY: AN OUTCOME AND INDEX OF NEUROTOXICITY.NEUROTOXICITY RESEARCH. VOL. 5. ISSUE 1-2. P. 111-117 | 54 | 86% | 11 |
2 | KOSTRZEWA, RM , KOSTRZEWA, JP , KOSTRZEWA, RA , KOSTRZEWA, FP , BRUS, R , NOWAK, P , (2011) STEREOTYPIC PROGRESSIONS IN PSYCHOTIC BEHAVIOR.NEUROTOXICITY RESEARCH. VOL. 19. ISSUE 2. P. 243-252 | 39 | 89% | 3 |
3 | KOSTRZEWA, RM , KOSTRZEWA, JP , BROWN, RW , NOWAK, P , BRUS, R , (2008) DOPAMINE RECEPTOR SUPERSENSITIVITY: DEVELOPMENT, MECHANISMS, PRESENTATION, AND CLINICAL APPLICABILITY.NEUROTOXICITY RESEARCH. VOL. 14. ISSUE 2-3. P. 121-128 | 41 | 87% | 8 |
4 | BREESE, GR , KNAPP, DJ , CRISWELL, HE , MOY, SS , PAPADEAS, ST , BLAKE, BL , (2005) THE NEONATE-6-HYDROXYDOPAMINE-LESIONED RAT: A MODEL FOR CLINICAL NEUROSCIENCE AND NEUROBIOLOGICAL PRINCIPLES.BRAIN RESEARCH REVIEWS. VOL. 48. ISSUE 1. P. 57-73 | 65 | 47% | 44 |
5 | KOSTRZEWA, RM , READER, TA , DESCARRIES, L , (1998) SEROTONIN NEURAL ADAPTATIONS TO ONTOGENETIC LOSS OF DOPAMINE NEURONS IN RAT BRAIN.JOURNAL OF NEUROCHEMISTRY. VOL. 70. ISSUE 3. P. 889 -898 | 52 | 68% | 53 |
6 | KOSTRZEWA, RM , (1995) DOPAMINE-RECEPTOR SUPERSENSITIVITY.NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. VOL. 19. ISSUE 1. P. 1-17 | 58 | 62% | 94 |
7 | KOSTRZEWA, RM , BRUS, R , PERRY, KW , (1999) INTERACTIVE MODULATION BY DOPAMINE AND SEROTONIN NEURONS OF RECEPTOR SENSITIVITY OF THE ALTERNATE NEUROCHEMICAL SYSTEM.POLISH JOURNAL OF PHARMACOLOGY. VOL. 51. ISSUE 1. P. 39 -47 | 51 | 68% | 4 |
8 | KOSTRZEWA, RM , KOSTRZEWA, JP , KOSTRZEWA, RA , NOWAK, P , BRUS, R , (2008) PHARMACOLOGICAL MODELS OF ADHD.JOURNAL OF NEURAL TRANSMISSION. VOL. 115. ISSUE 2. P. 287 -298 | 52 | 47% | 21 |
9 | READER, TA , DEWAR, KM , (1999) EFFECTS OF DENERVATION AND HYPERINNERVATION ON DOPAMINE AND SEROTONIN SYSTEMS IN THE RAT NEOSTRIATUM: IMPLICATIONS FOR HUMAN PARKINSON'S DISEASE.NEUROCHEMISTRY INTERNATIONAL. VOL. 34. ISSUE 1. P. 1 -21 | 74 | 42% | 44 |
10 | KOSTRZEWA, RM , HUANG, NY , KOSTRZEWA, JP , NOWAK, P , BRUS, R , (2007) MODELING TARDIVE DYSKINESIA: PREDICTIVE 5-HT2C RECEPTOR ANTAGONIST TREATMENT.NEUROTOXICITY RESEARCH. VOL. 11. ISSUE 1. P. 41-50 | 32 | 73% | 16 |
Classes with closest relation at Level 1 |